Xiao Yang

Dr. Xiao Yang


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 October 2018 in Acta Ophthalmologica
Verified
Journal Article
Closed access
PDF file
ZLZhouyue Li
Zhouyue Li
YHYin Hu
Yin Hu
DCDongmei Cui
Dongmei Cui
WLWen Long
Wen Long
MHMingguang He
Mingguang He
XYXiao Yang
Xiao Yang

16 September 2021 in JAMA Ophthalmology
Verified
Journal Article
Open access
PDF file
YHYin Hu
Yin Hu
FZFeng Zhao
Feng Zhao
XDXiaohu Ding
Xiaohu Ding
SZSheng Zhang
Sheng Zhang
ZLZhouyue Li
Zhouyue Li
MHMingguang He
Mingguang He
In December 2019, a novel coronavirus epidemic emerged in China and became a worldwide pandemic within several months. In response to the COVID-19 outbreak, many governments ordered strict quarantine and lockdown measures. Home confinement was imposed on an unprecedented scale. Schools and universities were closed nationwide and online courses were delivered. Following these efforts, the pandemic was effectively contained in China, as well as in some other areas of the world, by September 2020. However, factoring in the prolonged execution time of the measures, concerns have arisen over their collateral impact on children’s health.1 Specifically, there have been concerns that reduced outdoor activities and increased digital screen time might worsen the global burden of myopia.2-4

1 December 2017 in Contact Lens and Anterior Eye
Verified
Journal Article
Closed access
ZLZhouyue Li
Zhouyue Li
DCDongmei Cui
Dongmei Cui
YHYin Hu
Yin Hu
SASichun Ao
Sichun Ao
JZJunwen Zeng
Junwen Zeng
XYXiao Yang
Xiao Yang

13 October 2022 in British Journal of Ophthalmology
Verified
Journal Article
Closed access
PDF file
SXShengsong Xu
Shengsong Xu
ZLZhouyue Li
Zhouyue Li
WZWenchen Zhao
Wenchen Zhao
BZBingru Zheng
Bingru Zheng
JJJinyun Jiang
Jinyun Jiang
XYXiao Yang
Xiao Yang
Purpose To investigate the 2-year efficacy of atropine, orthokeratology (ortho-k) and combined treatment on myopia. To explore the factors influencing the efficacy. Methods An age-stratified randomised controlled trial. Children (n=164) aged 8–12 years with spherical equivalent refraction of −1.00 to −6.00 D were stratified into two age subgroups and randomly assigned to receive placebo drops+spectacles (control), 0.01% atropine+spectacles (atropine), ortho-k+placebo (ortho-k) or combined treatment. Axial length was measured at baseline and visits at 6, 12, 18 and 24 months. The primary analysis was done following the criteria of intention to treat, which included all randomised subjects. Results All interventions can significantly reduce axial elongation at all visits (all p<0.05). Overall, the 2-year axial elongation was significantly reduced in combined treatment than in monotherapies (all p<0.05). After stratification by age, in the subgroup aged 8–10, the difference between combined treatment and ortho-k became insignificant (p=0.106), while in the subgroup aged 10–12, the difference between combined treatment and atropine became insignificant (p=0.121). A significant age-dependent effect existed in the ortho-k group versus the control group (p for interaction=0.013), and a significant age-dependent effect existed in the ortho-k group versus the atropine group (p for interaction=0.035), which indicated that ortho-k can achieve better efficacy in younger children. Conclusions Atropine combined with ortho-k treatment can improve the efficacy of myopia control compared with monotherapy in children aged 8–12. Younger children might benefit more from ortho-k. Trial registration number ChiCTR1800015541.

16 September 2021 in JAMA Ophthalmology
Verified
Journal Article
Open access
PDF file
QLQian Li
Qian Li
LGLan Guo
Lan Guo
JZJiayu Zhang
Jiayu Zhang
FZFeng Zhao
Feng Zhao
YHYin Hu
Yin Hu
CLCiyong Lu
Ciyong Lu
Myopia is a common cause of vision loss that has increased in prevalence globally and is projected to affect nearly 5 billion people by 2050.1 In East Asia, the prevalence of myopia has been reported to be exceptionally high (73%) among school-aged children,2 and China is no exception.3 The prevalence of myopia among Chinese children and adolescents has been reported to be 53.6%, with 36.0% of children with myopia being primary school students.4 Early-onset myopia (aged ≤7 years) increases the risk of developing high myopia.5 High myopia is associated with various specific complications, including cataracts, chorioretinal atrophy, macular holes, myopic foveoschisis, and optic nerve head changes, which may lead to irreversible retinal photoreceptor damage and even central visual loss, ultimately generating a heavy burden for individuals, families, and society.6

31 January 2019 in British Journal of Ophthalmology
Verified
Journal Article
Closed access
PDF file
YHYin Hu
Yin Hu
CWCanhong Wen
Canhong Wen
ZLZhouyue Li
Zhouyue Li
WZWenchen Zhao
Wenchen Zhao
XDXiaohu Ding
Xiaohu Ding
XYXiao Yang
Xiao Yang
Background The myopia control effect of orthokeratology (OK) varies among individuals. The variation might relate to the proposed ‘areal summation effect’ of lens-induced visual signals. The current study evaluated the areal summed corneal power shift (ASCPS) in myopic children treated with OK lenses and assessed whether the ASCPS achieved at early post-OK visit can predict the lens long-term effect on the axial length (AL) elongation. Methods Study participants were 130 myopic children treated with OK lenses (age range, 8 to 15 years) in a prospective study. Corneal topography and AL were measured at baseline and 1, 3, 6, 9 and 12 months after OK lens wear. The ASCPS was derived from corneal topographic measurements and defined as the change in the areal summed corneal relative refraction at the follow-up visit from baseline. The impact of the ASCPS achieved at the 1 month post-OK visit on the 12 months AL elongation was examined using multivariate linear regression analysis. Results Baseline age of the study participants was 11.8 ± 1.8 years and their mean spherical equivalent was −3.00±0.92 D. The ASCPS was 6.90±6.09 D*mm at the 1 month visit and remained stable throughout the follow-up period (p=0.5508, repeated-measures analysis of variance). Greater 1 month ASCPS was associated with slower AL elongation at the 12 months visit (β=−0.007, p=0.001). Conclusions The ASCPS achieved at early post-OK visit is predictive for the lens long-term effect on the myopic AL elongation. The parameter is potential in guiding the OK lens practice to slow down axial growth in myopic children.